Proteomic biomarkers for prenatal bisphenol A-exposure in mouse immune organs

Environmental and Molecular Mutagenesis

Volumn 49, Issue 5, 2008, Pages 368-373

  Yang, Mihi ^a   Lee, Ho Sun ^a   Pyo, Myoung Yun ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Biomarker; Bisphenol A; Endocrine disrupting chemical; Prenatal; Proteomic

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; APOLIPOPROTEIN A1; MESSENGER RNA; BIOLOGICAL MARKER; DIPEPTIDYL PEPTIDASE; DIPEPTIDYL PEPTIDASE III; ENDOCRINE DISRUPTOR; PHENOL DERIVATIVE; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; EVALUATION; FEMALE; IMMUNOTOXICITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRENATAL EXPOSURE; PROGENY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEOMICS; SPLEEN; THYMUS; TISSUE SECTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; AGE; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PREGNANCY; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

ANIMALIA; MUS;

AGE FACTORS; ANIMALS; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DIPEPTIDYL PEPTIDASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOCRINE DISRUPTORS; FEMALE; MICE; MICE, INBRED ICR; PHENOLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEIN BIOSYNTHESIS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS; SPLEEN; THYMUS GLAND; UP-REGULATION; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 45849145763     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20394     Document Type: Article

References (21)

1. Agic D, Hranjec M, Jajcanin N, Starcevic K, Karminski-Zamola G, Abramic M. 2007. Novel amidino-substituted benzimidazoles: Synthesis of compounds and inhibition of dipeptidyl peptidase III. Bioorg Chem 35:153-169.
2. Ashby J, Tinwell H, Haseman J. 1999. Lack of effects for low dose levels of bisphenol A and diethylstilbestrol on the prostate gland of CF1 mice exposed in utero. Regul Toxicol Pharmacol 30:156-166.
3. Benninghoff AD. 2007. Toxicoproteomics - the next step in the evolution of environmental biomarkers. Toxicol Sci 95:1-4.
4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Bresnihan B, Gogarty M, Fitzgerald O, Dayer JM, Burger D. 2004. Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: A control mechanism of cytokine production? Arthritis Res Ther 6:R563-R566.
6. Byun J, Heo Y, Kim Y, Pyo M. 2005. Bisphenol A-induced downregulation of murine macrophage activities in vitro and ex vivo. Environ Toxicol Pharmacol 19:19-24.
7. Gianazza E, Eberini I, Villa P, Fratelli M, Pinna C, Wait R, Gemeiner M, Miller I. 2002. Monitoring the effects of drug treatment in rat models of disease by serum protein analysis. J Chromatogr B Analyt Technol Biomed Life Sci 771:107-130.
8. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R, Hayashi S. 2002. Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 29:175-192.
9. Inoue H, Tsuruta A, Kudo S, Ishii T, Fukushima Y, Iwano H, Yokota H, Kato S. 2005. Bisphenol a glucuronidation and excretion in liver of pregnant and nonpregnant female rats. Drug Metab Dispos 33:55-59.
10. Jiang X, Ellison SJ, Alarid ET, Shapiro DJ. 2007. Interplay between the levels of estrogen and estrogen receptor controls the level of the granzyme inhibitor, proteinase inhibitor 9 and susceptibility to immune surveillance by natural killer cells. Oncogene 26:4106-4114.
11. Kim CW, Cho EH, Lee YJ, Kim YH, Hah Y, Kim DR. 2006. Disease-specific proteins from rheumatoid arthritis patients. J Korean Med Sci 21:478-484.
12. Kim YH, Kim CS, Park S, Han SY, Pyo MY, Yang M. 2003. Gender differences in the levels of bisphenol A metabolites in urine. Biochem Biophys Res Commun 312:441-448.
13. Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC, Hochstrasser DF, Williams KL, Gooley AA. 1998. Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis 19: 837-844.
14. Munoz-de-Toro M, Markey CM, Wadia PR, Luque EH, Rubin BS, Sonnenschein C, Soto AM. 2005. Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology 146:4138-4147.
15. Nagao T, Saito Y, Usumi K, Yoshimura S, Ono H. 2002. Low-dose bisphenol A does not affect reproductive organs in estrogensensitive C57BL/6N mice exposed at the sexually mature, juvenile, or embryonic stage. Reprod Toxicol 16:123-130.
16. Nilsson O, Jakobsen AM, Kolby L, Bernhardt P, Forssell-Aronsson E, Ahlman H. 2004. Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors. Ann N Y Acad Sci 1014:280-283.
17. Park S, Lee M, Kim H, Jeoung D. 2002. Proteome analysis of 5-fluorouracil-resistance-associated protein in human gastric cancer cells. Biotechnol Lett 24:1141-1145.
18. Simaga S, Babic D, Osmak M, Sprem M, Abramic M. 2003. Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas. Gynecol Oncol 91:194-200.
19. vom Saal FS, Welshons WV. 2006. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ Res 100:50-76.
20. Yang M, Park MS, Lee HS. 2006a. Endocrine disrupting chemicals: Human exposure and health risks. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 24:183-224.
21. Yang M, Kim SY, Chang SS, Lee IS, Kawamoto T. 2006b. Urinary concentrations of bisphenol A in relation to biomarkers of sensitivity and effect and endocrine-related health effects. Environ Mol Mutagen 47:571-578.